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ABSTRACT  38 
The Hedgehog signalling pathway is crucial for development, adult stem cell maintenance, 39 
cell migration, and axon guidance in a wide range of organisms. During development, the 40 
Hh morphogen directs tissue patterning according to a concentration gradient. Lipid 41 
modifications on Hh are needed to achieve graded distribution, leading to debate about 42 
how Hh is transported to target cells despite being membrane-tethered. Cytonemes in the 43 
region of Hh signalling have been shown to be essential for gradient formation, but the 44 
carrier of the morphogen is yet to be defined. Here we show that Hh and its co-receptor 45 
Ihog are in exovesicles transported via cytonemes. These exovesicles present protein 46 
markers and other features of exosomes. Moreover, the cell machinery for exosome 47 
formation is necessary for normal Hh secretion and graded signalling. We propose Hh 48 
transport via exosomes along cytonemes as a significant mechanism for the restricted 49 
distribution of a lipid-modified morphogen.  50 
 51 
INTRODUCTION,  52 
The Hh molecule acts as a morphogen to regulate growth and cell fate specification at a distance. 53 
In different systems Hh is secreted from a restricted group of cells and distributed in a 54 
concentration-dependent manner according to distance from the source, resulting in differential 55 
activation of target genes1. Thus, Hh production, release, transport and reception must be kept 56 
under strict spatial and temporal control to accomplish an activity gradient. Hh gradient formation 57 
mechanisms have been studied extensively in the Drosophila wing imaginal disc comprising two 58 
cell populations with different adhesion affinities dividing the field into a posterior (P) and an 59 
anterior (A) compartment. The P compartment cells produce Hh, which moves across the A/P 60 
compartment border, decreasing in concentration as it spreads away from the border to the A 61 
compartment. Hh is post-translationally modified by the addition of cholesterol2 and palmitic acid3 62 
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which promote Hh association to lipid membranes but are essential for its restricted spreading4, 63 
raising the question of how its actual secretion and transfer are achieved.  In both the wing disc 64 
and the abdominal epidermis of Drosophila, specialized filopodia called cytonemes5 are crucial 65 
for establishment of the Hh gradient6. Cytonemes are easily visualized by confocal microscope in 66 
the basal part of the wing disc epithelium by expressing the Hh co-receptor Ihog6-8, which also 67 
labels punctate structures8 with a size 0.1 - 0.6 µm; some of them seem to exceed the cytoneme 68 
diameter, suggesting they could be extracellular vesicles (EVs)6. In the chicken limb bud, 69 
particles containing SonicHh (SHh) and CDO (vertebrate homologue of Ihog) have also been 70 
shown to travel along filopodia-like extensions within the field of SHh signalling9. Here we 71 
characterize these structures and their association with Hh, determining the role of EVs in Hh 72 
distribution and gradient formation.  73 
RESULTS 74 
Hedgehog is located in EVs that move towards recipient cells 75 
In the wing disc, Hh punctate structures (endogenous or ectopically expressed Hh-GFP) locate at 76 
the plasma membrane both apically and basolaterally (Fig. 1B), and in both P and A compartment 77 
cells near the A/P border1 (Fig.1C). Importantly, these puncta can be partially labelled by 78 
extracellular ex vivo staining with anti-GFP antibody (Fig.1 B-C), indicating the presence and the 79 
extracellular localization of Hh on their surface. They are more abundant at the basolateral part of 80 
the disc epithelium (Fig 1 B,C red and yellow puncta), and distinct from cytoplasmic puncta8 81 
(green puncta in Fig. 1C).  82 
 Co-expression of Hh-GFP and Ihog-RFP reveals puncta labelled with both markers in the 83 
A compartment, as well as puncta that just contain Hh-GFP probably due to internalization of Hh-84 
GFP vesicles by the receiving cells (Fig. 1D, see also Supplementary Movie 1). Live imaging of 85 
Ihog-RFP puncta in the abdomen, where Hh also acts as a morphogen10, confirms their presence 86 
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both laterally as well as basolaterally, similar to Hh (Supplementary Movie 2).  Disp11 and Dlp8, 87 
both essential for Hh release8, also co-localize with Ihog-labelled punctate structures and 88 
cytonemes (Fig. 1E-G). These results indicate that Hh could indeed be transported in 89 
extracellular vesicles (EVs) together with other pathway components, Ihog, Disp and Dlp, all 90 
involved in Hh release. The punctate structures localize to cytonemes in the basal side of the 91 
epithelium6; and as ex-vivo antibody staining marks both Disp and Hh, these proteins might all be 92 
at the surface of EVs (Supplementary Fig. 1G).   93 
 To further investigate the EV nature of the puncta, immuno-labelling for Hh in wing discs 94 
co-expressing Ihog-RFP and the mammalian EV marker CD63 tagged with GFP12 was 95 
performed, revealing a clear co-localization of the three in punctate structures (Fig. 2A). This co-96 
localization was also confirmed by live imaging in the abdominal epidermis of pupae co-97 
expressing CD63-GFP and Ihog-RFP (Fig. 2B and Supplementary Movie 3). Furthermore, 98 
immunoprecipitation of the GFP-tagged CD63 shows co-immunoprecipitation of Ihog-RFP and 99 
endogenous Hh in vivo (Fig. 2C-E), supporting the presence of CD63 in the Hh-Ihog complex 100 
observed by confocal imaging and strongly advocating the EV nature of the puncta (Fig. 2A-B). 101 
 Detailed observation of movies with CD63-GFP marked puncta shows their association 102 
with cytonemes in basal regions, where they move along the cytonemes which point from the P 103 
towards the A compartment (Fig.3 A-B and Supplementary Movie 4 and 5). Live imaging of cells 104 
expressing either the membrane marker CD4-Tomato or Ihog-RFP also shows punctate 105 
structures moving along cytonemes (Fig. 3C-D and Supplementary Movie 6 and 7, see also6).  106 
Interestingly, CD4-Tomato labelling occasionally shows buckling followed by a swelling structure 107 
which might be related to direct shedding of vesicles from the cytoplasmic membrane (Fig.3C and 108 
Supplementary Movie 6), also sporadically observed in puncta labelled with Ihog-RFP (Fig. 3D 109 
and Supplementary Movie 7).  110 
Hh in MVBs, plasma membranes and EVs by Immuno-EM  111 
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To analyse the distribution of Hh at the ultra-structural level, immunoelectron microscopy 112 
(Immuno-EM) was performed on thawed cryosections of wing discs expressing Hh-GFP. 113 
Supplementary Fig 1 (A-F) shows correlative light-electron microscopy of the Hh distribution on 114 
ultrathin cryosections cut orthogonal to the ventral/dorsal axis. Immunofluorescent Hh staining 115 
(Supplementary Fig. 1A) was detected along the whole apical disc lumen and at the basolateral 116 
region of the P compartment. At the EM level, apical Hh signal was found on microvilli 117 
membranes (Supplementary Fig. 1B) whereas basolateral staining on Hh producing cells was 118 
mainly detected within multivesicular bodies (MVBs) and lysosomes as well as on the basolateral 119 
membranes (Supplementary Fig. 1C,D,E). Interestingly, Hh staining was also detected on 120 
heterogeneous vesicle-like structures (size ranging from 30 to 200 nm) in basolateral extracellular 121 
spaces close to the basal lamina (Supplementary Fig. 1F,f). To further explore the extracellular 122 
distribution of Hh, wing discs expressing Hh-GFP were labelled ex vivo with an anti-GFP antibody 123 
before EM processing. As shown in Fig. 4A, thawed cryosections labelled with a dual fluorescent 124 
and electron-dense Fab´fragment probe showed apical staining and a basolateral punctate 125 
fluorescent pattern at the P compartment, fully consistent with the punctate labelling of external 126 
Hh observed at the confocal microscope (Fig. 1). In addition, at the EM level, immunogold 127 
staining detected Hh-GFP on apical microvilli membranes (arrows in Fig. 4B-B1) as well as on 128 
discrete regions of basolateral membranes (arrows in Fig. 4C-D), frequently associated with cell-129 
to-cell contacts (arrows in Fig. 4D). Importantly, significant Hh labelling was detected on clusters 130 
of vesicle-like structures at the basolateral extracellular spaces (arrows in Fig. 4C, E and F) and 131 
some of these vesicles appear also localized in association with cell protrusions (arrows in Fig. 132 
4E, insets). Finally, Immuno-EM confirmed the presence of Hh, Ihog and Disp at MVBs and 133 
exovesicles (Supplementary Fig. 1G,H, I) in cryosections of wing discs expressing Ihog-CFP and 134 
Disp-YFP, respectively. Altogether, these results support the notion that all these Hh signalling 135 
pathway components share the same secretion mechanism in exovesicles at basolateral spaces. 136 
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 Due to the size of some of these EVs (30-150 nm) and their association with MVBs, they 137 
could comprise bona fide exosomes13, defined as extracellular vesicles enriched in cholesterol, 138 
sphingomyelin, ceramide and components of membrane raft microdomains14. Exosomes originate 139 
from MVBs and are released to the extracellular space following fusion with the plasma 140 
membrane, containing proteins implicated in trafficking, membrane fusion and signalling15. Hh 141 
has been shown to traffic from apical to basolateral plasma membranes6-8 and this recycling 142 
process might actually localize Hh in MVBs. Both processes, Hh release8 and MVB formation, 143 
require Rab5, Rab4, and Rab8 function16,17.  144 
Hh-loaded exovesicles in culture cells 145 
Further characterization using Drosophila cultured wing disc cells, Cl8, as well as transfected S2 146 
cells expressing Hh-GFP also show the presence of endogenous Hh or Hh-GFP in EVs. These 147 
EVs have exosome-like features based on flotation density and protein markers (Fig. 5 and 148 
Supplementary Fig. 2A-B). Characterization of the vesicular fraction by isopynic density gradients 149 
shows co-fractioning of the Hh protein with membrane (TSG101, Rab11, Rab8 and Syntaxin), 150 
and luminal (Hsp70) exosomal associated proteins18 (Fig. 5B) and the Hh co-receptor Ihog 151 
(Supplementary Fig. 2C). Previously, it has been described that Hh is associated to lipoproteins 152 
(Drosophila apoliproteins; Lipophorins (Lp-I and Lp-II19) for transport12. Lp-II has also been 153 
detected in EV preparations in the presence of fly extracts (source of Lps in the Drosophila cell 154 
culture medium) but Lp-II does not co-fractionate with Hh-containing exosomes (Fig. 5A,B). 155 
Moreover, Hh loaded EVs were able to activate the Ptc::luciferase reporter (Fig. 5C-D), further 156 
showing that the Hh protein present in these EVs is functional.  157 
 Finally, interfering with proteins involved in the production/secretion of EVs, TSG101 and 158 
Rab2720-22 in Drosophila wing disc cells (Cl8 cells) leads to a significant reduction in the levels of 159 
Hh protein associated to EVs (Supplementary Fig. 2D). However, in our in vitro model, 160 
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interference with the ESCRT independent exosome production protein nSMase does not show a 161 
significant decrease in the Hh levels within EVs (Supplementary Fig. 2D). Together, results 162 
obtained from cell cultured EV analysis support the notion that at least a fraction of functional Hh 163 
is secreted in exosome-like vesicles in Drosophila cells. 164 
Exovesicle formation genes are needed for Hh release in vivo 165 
From an in vivo perspective, preliminary observations have shown a reduction of the Hh gradient 166 
when blocking EVs formation via RNAi treatment6. Further, in vivo RNAi screening confirmed the 167 
previously observed role of genes involved in EV formation and release, identifying new proteins 168 
involved in the graded secretion of Hh via EVs. Five RNAi treatments show an effect on the Hh 169 
gradient by the analysis of the Ptc::GFP-Enhancer-Trap expression, a recognized reporter for 170 
both, short- and long-range Hh responses: the ESCRT complex components Vps22 (ESCRT-II 171 
component) and Vps24 (ESCRT-III component), the ESCRT independent sorting protein 172 
SMase23, the SNARE complex component Ykt6 and the Drosophila homologous for the P4-173 
ATPase (CG31729), TAT-5 in C. elegans shown to regulate the budding of EVs from the plasma 174 
membrane (shedding vesicles/ectosomes/microparticles)24 (Fig. 6A a-d). All these proteins are 175 
involved in EV secretion pathways and Ykt6 has also been shown to be involved in the release of 176 
exosomes containing Wingless (Wg)25. In addition, in order to confirm the requirement of EV 177 
formation during Hh signalling, we have quantified the effect of knocking down a fraction of the 178 
genes identified over the long-range target Cubitus interruptus (Ci), and a significant decrease in 179 
activation was also observed (Fig 6A e-h). These experiments then endorse the necessity of the 180 
molecular machinery for EV formation and release for both short- as well as long-range Hh 181 
signalling. 182 
 To further analyse the effect of knocking down EVs production genes over Hh-loaded 183 
EVs in vivo, we ectopically expressed Hh-GFP or Ihog-RFP in producing cells, quantifying the 184 
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visible punctate structures only in the A compartment (Fig.6B and for methods Supplementary Fig 185 
3). We tested RNAi treatments with a clear effect in Hh signalling (Fig. 6A and6) including the 186 
ESCRT-0 protein Hrs26, the accessory ESCRT protein ALiX26, the EV component Anx B1127, the 187 
endosomal sorting protein Rab11 implicated in EV targeting28, and the lipid raft component Flo2 188 
also found in EVs29.  All RNAi treatments tested result in significantly fewer Hh-GFP puncta in the 189 
A compartment (Fig. 6Ba-c), showing an effect on actual Hh secretion. Similar reduction effects 190 
were also observed for Ihog-RFP puncta, confirming again the role of these genes in the 191 
regulation of the Hh pathway (Fig 6Bd). Moreover, interfering with EV production decreases the 192 
externalized levels of endogenous Hh (see Fig 6Cc expressed in levels of ratio change), shown 193 
by ex vivo staining after depletion only in the dorsal compartment of the disc while the ventral part 194 
retains wild type conditions (Fig. 6C a-b). Importantly, all RNAis used did not have a significant 195 
apoptotic effect after treatment (Supplementary Fig. 4A). In addition, quantitative RT-PCR 196 
experiments for four of these treatments confirmed the significant reduction of targeted RNA 197 
levels induced by the RNAis expression (Supplementary Fig.4B).  198 
 On the other hand, immunolabelling for total endogenous Hh levels of wing discs 199 
expressing the RNAi constructs only in the dorsal compartment, and compared to the wild type 200 
ventral compartment, show no significant change, excluding potential effects of RNAi treatments 201 
over production or degradation of intracellular Hh (Supplementary Fig. 4C). The only exceptions 202 
to the latter observation were the RNAi treatment for the ESCRT-I component TSG101 and the 203 
ESCRT-II component Vps22, which show significant accumulation of total Hh on the P 204 
compartment (paired t-test, t = -5.19, df = 7, p<0.01) (Supplementary Fig. 4Cc). However, despite 205 
this accumulation both TSG101 and Vps22 RNAi treatment still lead to a reduction in the 206 
extracellular levels of Hh (Fig. 6C). Thus, and taking into account all data from RNAi treatments, 207 
EV production is required for the normal release levels of Hh to the extracellular space in the wing 208 
disc and consequently for the normal graded signalling pattern.   209 
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DISCUSSION 210 
Our previous research showed a requirement for cytonemes extending from Hh producer cells 211 
towards receptor cells for Hh gradient formation, while Hh was also observed in punctate 212 
structures6. Here, we characterized these puncta confirming their EV nature and role during Hh 213 
signalling. These Hh-loaded exovesicles are a heterogeneous group, differing in size and 214 
potentially in origin. In vivo imaging shows puncta moving along cytonemes, suggesting a route of 215 
Hh secretion and restricted dispersion where Hh-containing EVs are transported by cytonemes. 216 
Nevertheless, to date we still do not know the precise mechanism used for Hh release and 217 
transport along the cytoneme. Ultrastructural analysis confirmed the presence of Hh in MVBs on 218 
the A compartment, supporting an ESCRT dependent route of exovesicle formation and release. 219 
Thus, it is possible that MVBs fuse to the plasma membrane releasing vesicles at the same time 220 
as cytonemes are elongating, and that these smaller vesicles either travel within the cytoneme 221 
(that could be small MVBs) or on the cytoneme. However, live imaging of these structures also 222 
shows puncta shedding directly from the cytonemes, and these might correspond to membrane-223 
derived vesicles known as shedding vesicles or ectosomes/microvesicles30.  224 
 Ectosome EVs were described as bigger than exosomes and more heterogeneous in 225 
size, ranging from 200 nm to greater than 1 µm in diameter, and are originated by shedding 226 
preceded by the budding of small cytoplasmic protrusions, which then detach by fission of their 227 
stalk30. Although shedding vesicles/ectosomes seem to have a different origin31, the mechanisms 228 
of their sorting process remain obscure and might also be dependent on the ESCRT complex24. 229 
In addition, studies have shown a crucial role for cholesterol-rich microdomains of the plasma 230 
membrane for shedding vesicle formation32 as well as for biogenesis of exosomes14. In our in vivo 231 
experiments, we have observed a decrease in Hh signalling by knocking down Vps22, an 232 
ESCRT-II complex component described as dispensable for vesicles derived directly from the 233 
plasma membrane33,34, but required for MVB formation35 (reviewed in 36) supporting an MVB 234 
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fusion origin. However, we have also observed a decrease in signalling and Hh release when 235 
interfering with P4-ATPase (CG-31729), the Drosophila ortholog of TAT-5 specifically involved in 236 
the formation of ectosomes in C. elegans24. Thus, as it is difficult to account for the considerable 237 
differences between the two types of vesicles, the result of knocking down Vps22 and P4-ATPase 238 
together with the EM data and the in vivo imaging indicate that Hh might be released in both 239 
ectosomes/microvesicles and exosome-like vesicles. Determining which process might be the 240 
main one regulating Hh secretion or whether both processes are linked is a future challenge. 241 
 In vitro, functional tests demonstrate that Hh loaded exovesicles fractionate together with 242 
classical exosomal markers (Fig 5B), and are able to activate Hh dependent transcription in cell 243 
culture (Fig 5D). Furthermore, interference with genes involved in the formation and release of 244 
EVs in vivo has a decreasing effect on the release of Hh to the extracellular space, altering the 245 
Hh gradient formation during signalling (Fig 6). In our experimental model (the Drosophila wing 246 
imaginal disc) all RNAi treatments behave similarly, independently of their individual function 247 
within the EVs formation pathways. The only exceptions were given by the silencing of ESCRT-I 248 
component TSG101 and the ECRT-II component Vps22, which resulted in a significant 249 
accumulation of total Hh in the P compartment (Supplementary Fig. 4C) but still impaired Hh 250 
secretion to the A compartment (Fig. 6B,C); probably due to a simultaneous impairment of the 251 
route for Hh degradation as they both play a key role in MVB formation26,35. Differential outputs 252 
after down regulation of different EVs formation genes have been reported, including an 253 
increment in EVs release (eg ALiX RNAi)26. However, there is increasing evidence of the 254 
heterogeneous nature of EVs in size, protein content and origin18. Depletion of a gene involved in 255 
the formation pathway might either affect EVs release in general or might alter the proportion of 256 
the different vesicles formed26. Thus, quantifying the effects over those vesicles containing Hh or 257 
Ihog might not detect potentially distinct changes in the distribution of different size vesicles or 258 
protein content.   259 
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 Association of Hh to EVs and thus membranes supports the transport mechanism initially 260 
proposed by Greco et al37 for the spread of Wg protein; Wg secreted and moved while contained 261 
in membrane fragments called argosomes. Vesicular release of SHh has also been described in 262 
the determination of left-right asymmetry in vertebrates38. Moreover, Hh has been found in 263 
exosomal structures for its apical secretion in C. elegans39. We have found a functional Hh 264 
associated to heterogeneous EVs, either originated from MVBs or/and directly shedding from the 265 
plasma membrane of cytonemes, and that are essential for Hh gradient formation.  266 
 Recent reports also show Wg and Wnt to be released in exosomes at the wing disc, in 267 
the zebrafish and tissue culture cells21,22,25,40. During patterning of the zebrafish neuroectoderm, 268 
Wnt8a localizes to membrane-associated punctate structures in live tissue and these puncta are 269 
found on filopodial cellular processes40. In Drosophila, Wg has also been visualized in vivo 270 
moving along cellular extensions by Evi-exosomes18 or released as exosomes from MVBs at 271 
synaptic terminals22. The release of exosomes and further activation of the Hh pathway in an 272 
epithelium might then require a synaptic process with a potential complex association of various 273 
proteins. Thus, in vitro experiments with cultured cells might not be able to reproduce the 274 
signalling process in an epithelium, leading to the relatively low representation of Hh in exosomes 275 
and Hh dependent transcription activation.  276 
 Overall, our results support a route for morphogen transport that involves vesicle 277 
transport and secretion along cytonemes to accomplish proper spatially restricted signalling. Still, 278 
key unanswered questions regarding the final transfer or release of morphogens like Hh remain. 279 
Supporting a conserved mechanism in vertebrates, SHh and CDO (vertebrate homologue of 280 
Ihog) in vesicle-like structures have been observed moving along specialized filopodia in the 281 
chick limb bud9. Further elucidation of the origin, structure and function of the EVs implicated in 282 
this process as well as the mechanism of their release is likely to be essential to understand Hh 283 
cell-cell signalling. However, our results do not totally exclude a potential combinatorial effort with 284 
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other secretion routes or extracellular forms of Hh, such as lipoprotein particles12,41 or Hh 285 
multimers42. Comprehending how signalling molecules like Hh are distributed will improve 286 
knowledge of developmental processes and their role in diseases like cancer, revealing a wider 287 
set of mechanisms and genes involved in the regulation of their signalling. 288 
METHODS  289 
Fly mutants. 290 
A description of mutations, insertions and transgenes (Supplementary Table 1) is available at Fly 291 
Base (http://flybase.org/). Gal80ts, FLP122 (Bloomington Drosophila Stock Centre (BDSC), 292 
Indiana, USA; http://flystocks.bio.indiana.edu).  293 
Overexpression experiments 294 
The Gal4 drivers were: hh.Gal444, ap.Gal4 45, tub.Gal4 (BDSC). The pUAS-transgenes were: 295 
UAS.Hh-GFP46, UAS.Ihog-RFP8, UASCD63-GFP12, and UAS.CD4-tdTom47.  296 
UAS-RNAi lines targeting TSG101 (35710), ALiX (33417), Hrs (33900), Rab27 (37774), Vps 22 297 
(38289), Vps 24 (38281), aSmase (25283) and Ykt6 (38314) were all from BDSC. Flo2 (31525), 298 
AnxB11 (29693), Rab11 (108382), P4-ATPase (CG31729) (105987) and Vps4 (105977) were 299 
from the IMP Vienna Drosophila RNAi Centre (VDRC; http://stockcenter.vdrc.at). 30 hours of 300 
transient expression of the UAS-constructs using Gal4; Tub-Gal80ts drivers was achieved by 301 
maintaining the fly crosses at 18ºC and inactivation of Gal80ts at the restrictive temperature 302 
(29ºC) before dissection. 303 
Immunostaining of imaginal discs 304 
Immunostaining was performed according to standard protocols48. Imaginal discs from third instar 305 
larvae were fixed in 4% paraformaldehyde/PBS for 20 min at room temperature (RT) and washed 306 
in PBT before incubating with PBT 0.2% BSA for blocking (1 hour at RT) and primary antibody 307 
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incubations (overnight at 4°C). Incubation with fluorescent secondary antibodies (1/200 Jackson 308 
laboratories and Invitrogen) was performed for 2 hours at RT for posterior washing and mounting 309 
in mounting media (Vectashield). Antibodies were used at the following dilutions: rabbit polyclonal 310 
anti-Hh (1:800 or 1:500, raised in this work); rat monoclonal anti-Ci50 (1:20 dilution, a gift from B. 311 
Holmgren); rabbit polyclonal anti-GFP antibody (1:500, Molecular Probes, A-6455); and rabbit 312 
polyclonal anti-Caspase 3 antibody (1:50 dilution, Asp-175 from Cell Signalling). The protocol for 313 
the ex-vivo labelling using anti-GFP antibody is described in46. Imaginal discs from third instar 314 
larvae were dissected on ice, transferred immediately to ice-cold M3 medium containing anti-Hh 315 
(1:30 dilution; rabbit antibody raised for this work), or anti-GFP (1:50 dilution, rabbit antibody A-316 
6455; Invitrogen), or anti-Disp8 (1:50 dilution, guinea pig antibody), or anti-Dlp (1:5 dilution; 317 
mouse antibody, Hybridome bank, Iowa) antibodies and incubated at 4°C for 30 minutes. The 318 
incubation with the primary antibody under these `in vivo' conditions, without detergents prior to 319 
fixation, rendered the antibody incapable of penetrating the cells. They were then washed in ice-320 
cold PBS, fixed in PBS 4% PF at 4°C, washed in PBT and incubated with secondary fluorescent 321 
antibody as above.  322 
In vivo imaging of the abdomen 323 
Pupae were filmed through a window in the pupal case and analysed as described previously6. 324 
White prepupae were attached to double-sided adhesive tape to remove the operculum with 325 
forceps. The prepupa was removed from the adhesive in a solution of 1 mM levamisole in water 326 
and moved to a new slide mounting between three bands of Parafilm “M” arranged in a U-shape 327 
to ensure minimal squashing. A total of 30 µl of 1 mM levamisole was used to surround the 328 
prepupa. A coverslip was placed over the sample, and the open part of the chamber was filled 329 
with 100 µl voltalef oil to ensure an oxygen supply. All imaged flies developed into pharate adults 330 
and many hatched. Z-stacks of around 40 µm with a step size of 2.5 or 3 µm were recorded 331 
every 150-180 seconds using a Leica SP8 confocal microscope at room temperature. 332 
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Number (N) of recorded pupae: Supplementary movie 2+7, N = 8; Supplementary Movie 3, N = 3; 333 
Supplementary Movie 4+5, N = 9; Supplementary Movie 6, N = 6. 334 
Microscopy and image processing of imaginal discs 335 
Laser scanning confocal microscopes (LSM510 or LSM710 Vertical; Zeiss) were used for 336 
confocal fluorescence imaging of imaginal discs. ImageJ software (National Institutes of Health) 337 
was used for image processing and for determining fluorescence levels.  338 
Quantification of EVs and Hh levels 339 
Vesicle number (Fig. 6B) was quantified using ImageJ. A defined rectangular area of 170x75 µm 340 
was chosen, which was located in the A compartment in the vicinity of the P compartment 341 
(Supplementary Fig. 3A,B). The edge limit of the P compartment cells was defined after blurring 342 
of the projected image and by creating a shaped selection to delimit edges (Supplementary Fig. 343 
3a,b) also confirmed by the immuno-labelling of the A compartment Ptc expression 344 
(Supplementary Fig. 3C). Within the selection a mean filter of 1 pixel radius was used to smooth 345 
the image and remove noise. To remove particles that were of low fluorescence intensity, the 346 
lower threshold for pixel intensities was set to 60, whereas the upper was kept at 255. Finally, the 347 
“Analyse Particles” tool was used to count puncta within 0-4.5 pixels of size (Supplementary Fig. 348 
3a,b). Quantifications were performed using individual Z slices taken every 1µm. All images were 349 
treated identically. For all RNAi treatments a control for potential cell death due to RNAi treatment 350 
was performed by immune-staining with anti-Caspase antibody (see Supplementary Fig. 4A); no 351 
significant increment of cell death due to treatment was detected. 352 
Levels of externalized Hh (Fig. 6C) and total Hh (Supplementary Fig. 4C) were quantified 353 
by determining the Mean Gray Value in ImageJ. A rectangular area of approximately 14,400 354 
pixels within the wing pouch on each side of the dorso-ventral border marked by GFP expression 355 
driven by the ap.Gal4 was used.  356 
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Quantification of gradient length 357 
Gradient lengths were determined as described in 6 and then expressed as a proportion of the  358 
wing pouch length (Fig. 6 A). 359 
Quantitative RTqPCR 360 
The RNAis’ ability to down regulate their target genes in the transgenic flies was already tested 361 
by the manufacturer (BDSC Trip toolbox stocks). Four RNAi treatments were tested 362 
(Supplementary Fig. 4B). Three independent biological replicate assays were produced for 363 
TSG101-, Flo2-, Rab11-, and the control EGFP-RNAi constructs, and six replicates in the case of 364 
HRS- and its control EGFP-RNAi.  For RNA extraction Drosophila third instar larvae expressing 365 
RNAi constructs or not were collected and kept at -80ºC. Larval tissues were homogenized in 366 
500µl Trizol (Invitrogen), 100µl Chloroform (Merck). After a 15 min 12000 rpm centrifugation at 367 
4ºC the upper phase containing total RNA was collected and precipitated with 250µl 2,3-propanol 368 
(Merck). The dry pellets were resuspended in 40µl sterile water and stored at -80ºC. For the RT-369 
qPCR reaction, RNA concentration was measured using the Nanodrop ND-1000 and RNA 370 
integrity was confirmed using the “Total RNA Analysis ng sensitivity (Eukaryote)” assay of the 371 
Agilent 2100 bioanalyzer. cDNA was generated using Super Script III First-Strand Synthesis 372 
SuperMix for qRT-PCR from Invitrogen (PN 11752250), 800 ng of total RNA were used for each 373 
replicate in a final volume of 20 ul (final concentration of 40 ng/µl). qPCR reactions (95°C for 10 374 
min., followed by 40 cycles of 95°C for 15sec. and 60°C for 30sec.; and 1 cycle of 95ºC for 375 
15sec, 60ºC for 15sec and 95ºC  for 15sec) were run on the CFX 384 (Biorad) according to the 376 
manufacturer's instructions. 377 
Primers used in RTqPCR: 378 
 Flo2_1F 5’-GGCGATGCAGCAATTATGA-3’, Flo2_1R 5’-TCATCGGTTTTGGCCAGT-3’, 379 
Flo2_2F 5’-GACGCAAGCAGATCGAGATT-3’, Flo2_2R 5’-GATGGTCTGACATTGCTTGG-3’, 380 
Rab11_1F 5’-GACATTGCCAAGCATCTGAC-3’, Rab11_1R 5’-GTTCTGGTCGGCATGGTC-3’, 381 
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Rab11_2F 5’-AGCCACAGTTTGTCATGTGC-3’, Rab11_2R 5’-TCTGATGATGGTGGTGGTGT-3’ 382 
Hrs_1F 5’-AAGATGAACTCGCCCAACC-3’, Hrs_1R 5’-GCAGTTCTTGACGATGCTCTC-3’, 383 
Hrs_2F 5’-TCACTCCCAAGAATGCCTTT-3’, Hrs_2R 5’-GAGGGAATAGCAGGAGGAGTG-3’, 384 
TSG101_1F 5’-GACCTGCAGAGGTTCGTGTT-3’, TSG101_1R 5’-385 
CGGGAATAGTGCCCTGTATG-3’, TSG101_2F 5’-CTTATATGCCTCAGCCTGGTG-3’, 386 
TSG101_2R 5’-GCTGTGGGATAAGGCAGAAA-3’, Actin-F 5’-387 
CACCTGCACACCATCATCATTAT-3’, Actin_R 5’-CACACAACATGCGCCCAA-3’, Tub_F 5’-388 
TCCAATCGCAACAAAAAATTCA-3’, Tub_R 5’-TCGTTTTCGTATGCTTTTCAGTGT-3’, RP49_F 389 
5’-GACGCTTCAAGGGACAGTATCTG-3’, RP49_R 5’-AAACGCGGTTCTGCATGAG-3’  390 
Statistical Analysis  391 
All statistical analysis was carried out in R51.  Data were tested for normality using Shapiro-Wilk 392 
tests (data were logged for normality where required), and for homogeneity of variance using 393 
Bartlett tests.  394 
Models for treatment effects on gradient length 395 
For the Ptc reporter a Kruskal Wallis test of gradient length against treatments related to 396 
exovesicle production (Wildtype, UAS-aSmase-RNAi, UAS-Vps22-RNAi, UAS-Vps24-RNAi, UAS-397 
Ykt6-RNAi, UAS-CG31729 (P4ATPase)-RNAi) (n=65) showed a significant effect of treatment 398 
(Chi2=34.11, df=5 P<0.001). Pairwise Wilcoxon tests adjusted for multiple comparisons were 399 
used to test for differences between control and each treatment (Fig. 6 Ad). For the Ci reporter a 400 
Kruskal Wallis test of gradient length against treatments related to exovesicle production 401 
(Wildtype, UAS-Hrs-RNAi, UAS-Vps22-RNAi, UAS-Vps4-RNAi, UAS-Anxb11-RNAi, UAS-402 
TSG101-RNAi, UAS-Vps24-RNAi, UAS-aSmase-RNAi), (n=87) showed a significant effect of 403 
treatment (Chi2=36.89, df=7 P<0.001). Pairwise Wilcoxon tests adjusted for multiple comparisons 404 
were used to test for differences between control and each treatment (Fig. 6Ah). 405 
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Models for treatment effects on number of EVs released  406 
A Kruskal Wallis test of the number of Hh-GFP puncta released for the control (UAS-Hh-GFP) 407 
and ten EVs related treatments (UAS-ALIX-RNAi, UAS-AnxB11-RNAi, UAS-CG31729 408 
(P4ATPase)-RNAi, UAS-Rab11- RNAi, UAS-Hrs-RNAi, UAS-Vps4-RNAi, UAS-Flo2-RNAi, UAS-409 
TSG10-RNAi, UAS-YKT6-RNAi, UAS-aSmase-RNAi)(n=103) showed a significant effect of 410 
treatment (Chi2=54.67, df=10 P<0.001). Pairwise Wilcoxon tests adjusted for multiple 411 
comparisons were used to test for significant differences between control and each treatment (Fig 412 
6Bc). 413 
A Kruskal Wallis test carried out for the number of IhogRFP puncta released for the control (UAS-414 
Ihog-RFP) and seven treatments related to exosome production (UAS-Alix-RNAi, UAS-TSG101-415 
RNAi, UAS-AnxB11-RNAi, UAS-Rab11-RNAi, UAS-Hrs-RNAi, UAS-Vps4-RNAi, UAS-Flo2-RNAi) 416 
(n=76) showed a significant effect of treatment (Chi2=31.18, df=7, P<0.001). Pairwise Wilcoxon 417 
tests adjusted for multiple comparisons were used to test for significant differences between 418 
control and each treatment (Fig 6Bd).. 419 
Models for treatment effect on endogenous levels of external Hh  420 
A paired t-test comparing the relative fluorescence (mean gray values) for WT tissue and for 421 
RNAi treated tissue (UAS-TSG101-RNAi, UAS-Rab11-RNAi, UAS-Hrs-RNAi, UAS-Vps22-RNAi) 422 
(n=56) showed a significant difference (t = 13.18, df = 55, P<0.001). The Ratio WT:ap was tested 423 
for difference between RNAi expressing wing discs and discs without RNAi treatment or Control, 424 
using Anova  (F4,51=7.79, P>0.001). Tukey’s Honest significant difference tests were used to test 425 
for differences between control and each treatment (Fig 6Cc). 426 
Models for treatment effect on endogenous levels of total Hh 427 
Paired t-tests comparing the relative fluorescence (mean gray values) for WT tissue and for RNAi 428 
treated tissue (UAS-TSG101-RNAi, UAS-Hrs-RNAi, UAS-AnxB11-RNAi, UAS-Flo2-RNAi, UAS-429 
Vps22-RNAi, and UAS-CG31729-RNAi (P4-ATPase) (n=49) showed non-significant differences, 430 
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except for the TSG101 (t = -5.19, df = 7, p<0.01) and Vps22 (t=-5.50, df=7, p<0.001) treatments. 431 
The Ratio WT:ap was tested for difference between RNAi expressing wing discs (ap) and discs 432 
without RNAi treatment or control (WT), using Anova  (F6,42 = 11.7, p<0.001). Tukey’s Honest 433 
significant difference tests showed that the only significant differences with control were for 434 
TSG101 (p<0.05) and Vps22 (p<0.001) (Supplementary Fig. 4Cc). 435 
Models for treatment effects on target RNA levels 436 
 Welch two sample T-tests comparing the normalized values for RNA expression for WT tissue 437 
and for each RNAi treated tissue (UAS-TSG101-RNAi, UAS-Flo2-RNAi, UAS-Rab11-RNAi, UAS-438 
Hrs-RNAi) showed significant differences between RNAi expressing larvae and larvae without 439 
RNAi treatment or Control (Supplementary Fig. 4B). Values for each treatment are: TSG101 440 
RNAi against Control (n=6) (t=3.63, df=3.6 p<0.05), Flo2 RNAi against Control (n=6) (t=9.19, 441 
df=2.5 p<0.005), Rab11 RNAi against Control (n=6) (t=18.2, df=2 p<0.005), HRS RNAi against 442 
Control (n=12) (t=4.08, df=8.3 p<0.005). 443 
Immunoelectron Microscopy 444 
Larvae were inverted in PBS and fixed in 2% (w/vol) paraformaldehyde (PFA) and 0.2% (w/vol) 445 
glutaraldehyde (GLA) or 4%PFA and 0.05% GLA in 0.2 M phosphate buffer (PB, pH 7.4) for 2 h 446 
at room temperature and kept in 1% (w/vol) PFA in PB at 4 °C. Subsequently, wing discs were 447 
dissected, embedded in 10% (w/vol) gelatine, and processed for cryosectioning. Discs were then 448 
cut orthogonal to the ventral/dorsal axis on an EM FCS cryo-ultramicrotome (Leica Microsystems) 449 
at -120 °C. For immunogold labelling, thawed 90-nm thick cryosections were incubated with 450 
rabbit anti-GFP (1:500, A-6455; Invitrogen, rabbit anti-Hh (1:150) (6), guinea pig anti-Disp (1:100) 451 
antibodies followed by protein A conjugated to 15-nm gold particles (EM Laboratory, Utrecht 452 
University, The Netherlands). Sections were stained with a mix of 1.8% methylcellulose and 0.4% 453 
uranyl acetate. For double labelling, anti-Disp8 and anti-Hh48 antibodies were detected with goat 454 
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anti-guinea pig IgG conjugated to 10-nm gold particles and goat anti-rabbit IgG conjugated to 15-455 
nm gold particles (British Biocell), respectively.  456 
 For ex vivo anti-GFP labelling experiments, discs expressing Hh-GFP were labelled 457 
with 1:30 dilution anti rabbit anti-GFP polyclonal antibody (Life technologies (Molecular Probes)) 458 
as reported46 and fixed with 4%PFA and 0.05% GL in 0.2 M PB (pH 7.4) for 2h at RT. Then, the 459 
discs were processed for cryosectioning as described before. Ultrathin (100 nm) thawed 460 
cryosections were incubated with an anti-rabbit Fab´ fragment conjugated to Alexa594 and 1.4-461 
nm nanogold (Fluoronanogold, Nanoprobes, New York, USA), mounted with 50% glycerol and 462 
visualized with an inverted fluorescence microscope (DMI6000, Leica Microsystems, Wetzlar, 463 
Germany). For EM visualization, nanogold labelling was amplified by silver enhancement 464 
according to manufacturer’s instructions (Nanoprobes). Sections were then stained with a mixture 465 
of methylcellulose and uranyl acetate and visualized with a JEOL JEM 1010 (Tokyo, Japan) 466 
electron microscope operating at 80 kV. Images were recorded with a 4k x 4k CMOS F416 467 
camera from TVIPS (Gauting, Germany). 468 
Immunoprecipitation  469 
We modified a standard protocol for immunoprecipitation using Drosophila embryos52. Larvae 470 
expressing CD63-GFP, Ihog-RFP or co-expressing both under tub.Gal4 were collected and dry 471 
frozen in liquid Nitrogen. 50 frozen larvae for each genotype were homogenized in 1 ml/each of C 472 
Buffer (50mM HEPES [pH7.4], 50mM KCl, 1mM MgCl, 1mM EGTA, 0.1% Triton, Protease 473 
inhibitors cocktail [Roche] and 1mM PMSF). Extracts were initially clarified by centrifugation at 474 
35,000 x g for 10 min, followed by two consecutive high-speed centrifugations at 35,000 RPM for 475 
10 min and the second for 30 min. Clarified supernatant was transferred to fresh tubes between 476 
each spin. The supernatant was then incubated with GFP-Trap coupled to agarose beads 477 
(Chromoteck) for 1 hour at 4°C, followed by washing (5X) with C Buffer. Immunoprecipitated 478 
samples were resuspended in sample buffer with DTT and subjected to 1 D SDS-Page and 479 
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Western blotting. Blotted membranes were probed with appropriate antibodies, either to RFP 480 
(1:5000, Abcam) or GFP (1:1000, Sigma). After antibody stripping (Tris-HCL 0.5 M, pH 6.8, 2% 481 
SDS and b-mercaptoethanol 0.1 M, for 30 min at 60°C) membranes were probed with anti-Hh 482 
(rabbit antibody raised for this work 1:5000). Uncropped Western blots are shown in 483 
Supplementary Fig. 5 A-C. 484 
Cell culture 485 
Drosophila S2 cells stably-expressing full-length Hh fused to green fluorescent protein (S2::Hh-486 
GFP) were generated using the multicistronic vector pAc5-STABLE2-Neo53, and cultured in 487 
Schneider's medium supplemented with 10% FBS and 1% penicillin/streptomycin at 25°C. Cl8 488 
cells were cultured in M3 medium containing 2.5% of FBS, 2.5% fly extract, 10 mg/ml of insulin 489 
and 1% penicillin/streptomycin. Transient transfections of Cl8 cells were performed using X-490 
tremeGENE transfection reagent (Roche Applied Science) following manufacturer’s instructions 491 
on 25 million (5 million/ml) cells and 6 µg of DNA per transfection experiment. 492 
Production and isolation of EVs 493 
Crude preparation of EVs from Hh-GFP transiently transfected Cl8 cells were obtained by 494 
collecting 5 ml of EV-depleted media and performing differential centrifugation at 2,000 x g and 495 
100,000 x g of the supernatants after 48 h transfection period. The pellets containing crude EVs 496 
were resuspended. For EV production of S2::Hh-GFP and Cl8 cells,  400 million cells were 497 
cultured for 48-h and 96-h, respectively, in EV-depleted media (2.5 millions/ml), and exosomes-498 
enriched EVs secreted into the medium were purified as previously described54; briefly, culture 499 
supernatant was collected and centrifuged at 2,000 x g, 4°C, for 10 min to remove cells. The 500 
resultant supernatant was subjected to filtration through 0.22 μm pore filters, followed by 501 
ultracentrifugation at 10,000 x g and 100,000 x g for 30 min and 60 min, 4°C, respectively. The 502 
resulting pellets were washed with PBS and again submitted to ultracentrifugation at 100,000 x g, 503 
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4°C, for 60 min.  Final pellets were suspended in PBS and stored at - 80ºC. 504 
Western blot analysis 505 
A small portion (1/350th) of the supernatants obtained after 2,000 x g and 100,000 x g, and 1/5th 506 
of the crude EVs preparations or of the fractions from the sucrose gradient were analysed by 507 
Western-blotting. Extracts from larvae stage 3 (L3) were prepared as described7. SDS-sample 508 
buffer was added to the samples and incubated for 5 min at 37ºC, 65ºC and 95ºC and separated 509 
on 4-12% pre-casted acrylamide gels (Invitrogen, Carlsbad, CA) under non-reducing conditions. 510 
Gels were transferred to PVDF membranes and blocked (5% milk and 0.05% Tween-20 in PBS) 511 
for antibody incubation. Chemoluminescent detection of proteins was performed using ECL Prime 512 
(Amersham) or Clarity Western ECL substrate (Biorad). Monoclonal antibodies were purchased 513 
from the vendors indicated: anti-GFP (clones 7.1 and 13.1) from Roche, anti-GFP (clone GFP-20) 514 
for co-immunoprecipitation experiments from Sigma, anti-RFP (ab62341) from Abcam, anti-515 
Hsp70 (BRM-22) from Santa Cruz Biotech. Inc (Santa Cruz, CA), anti-TSG101 (4A10) from 516 
Abcam, anti-Rab11 (clone 47) and anti-ubiquitin (clone 6C1.17) from BD Biosciences (Mountain 517 
View, CA), anti-ApoLII55 and anti-Syntaxin (8C3) from Developmental Studies Hybridoma Bank 518 
(Iowa City, IA). Rabbit polyclonal anti-Hh and anti-Ihog were obtained using the Polyclonal 519 
Genomic Antibody TechnologyTM (sdix)56. For the anti-Hh production, the immunogen region 520 
used comprised the DmHh amino-acids region 80-256; as for the anti-Ihog the DmIhog amino-521 
acid region 248-488 was used. Horseradish peroxidase (HRP)-conjugated secondary antibody 522 
was from GE-Healthcare (Buckinghamshire, UK). Uncropped Western blots are shown in 523 
Supplementary Fig. 5 D-I. 524 
Fractionation of EVs on continuous sucrose gradient 525 
A continuous 0.25–2 M sucrose gradient in 20 mM HEPES (pH 7.4) was performed as described 526 
in57. Briefly, EVs were put on top of the continuous sucrose gradient and submitted to 527 
ultracentrifugation for 16 h at 210 000 × g, 4°C, in a SW40Ti swinging-bucket rotor. By using an 528 
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auto densi-flow density gradient fractionator (Labconco, Kansas City, MO, USA), one millilitre 529 
fractions were collected from top to bottom and 20 µL of each fraction were reserved for 530 
measurement of the refractive index to density determination. Each fraction was diluted with 2 mL 531 
of 20 mM HEPES (pH 7.4) and ultra-centrifuged for 1 h at 100 000 × g, 4°C, in a TLA-110 rotor. 532 
Supernatants were aspirated and pellets were suspended in 25 µL PBS and stored at −80°C. 533 
Gene silencing in Drosophila cultured Cl8 cells  534 
nSMase, TSG101 and Rab27 dsRNAs were synthesized following the protocol used at the 535 
Drosophila RNAi Screening Centre (DRSC) in Boston. Briefly, DNA templates containing T7 536 
promoters sequence on both ends were obtained from the DRSC and were amplified by PCR. 537 
These PCR products were used for the in vitro transcription (IVT) reaction, which was carried out 538 
for 16 h at 37ºC using the T7 Megascript kit from Ambion. After DNaseI (Ambion) digestion to 539 
remove the template DNA, the dsRNAs were purified using RNAeasy columns (QIAGEN). Both 540 
PCR-amplified DNA and purified dsRNA products were assessed by gel electrophoreses and 541 
absorbance measurements of the yield. Cl8 cells were seeded in six-well plates at 2×106 per well 542 
in 0.5 mL of FBS-free medium and 7.5μg of dsRNA were added and incubated for 1h, adding 543 
then 1.5 mL of EV-depleted medium. After 48 h of incubation a new dose of dsRNA was added 544 
and after another 48h of incubation the supernatants were collected and centrifuged at 2 000 x g 545 
for 10 min to remove cells, then centrifuged at 100 000 × g for 1 h, 4°C, in a TLA-110 rotor. The 546 
resulting pellets were suspended in 25 µL of PBS and stored at −80°C for subsequent analysis 547 
by Western blotting. 548 
Luciferase activity assay of Hh EVs on cultured Drosophila cells  549 
Cl8 cells were transfected with ptcΔ136-GL3 Firefly responsible reporter 58.  After 24 h, cells 550 
were lifted and seeded into 96-wells plate, and 8-hours later incubated with 0.2 ng/ul of Shh 551 
recombinant protein (Sigma) or 1/4th of the crude EVs. After 24 h of treatment, Firefly luciferase 552 
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levels were measured using the Dual-Glo Luciferase Assay System (Promega) and the ratio to 553 
the control (no EVs added) was calculated to give the Hh signalling activity. This was tested in 554 
triplicate and significant differences were tested by a t-student test. 555 
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FIGURE LEGENDS. 591 
Figure1: Hh and key signalling components are present in EVs and cytonemes. A) 592 
Schematic representation of a cross-section of the wing disc showing the expression of Hh 21 in 593 
both epithelia; Disc proper (DP) and peripodial membrane 59. B) Transverse section of a 594 
hh.Gal4>UAS.HhGFP wing disc which has been ex-vivo stained with anti-GFP antibody for one 595 
hour at low temperature to avoid HhGFP internalization. Note the colocalization of HhGFP21 and 596 
externalized GFP (red) mainly at the basolateral part of the disc epithelium (bottom of image). C) 597 
Confocal sections of a similar hh.Gal4>UAS.HhGFP wing disc ex-vivo stained with anti-GFP 598 
antibody. Note that the colocalization of green 60 and red (externalized Hh) is increased in more 599 
basolateral sections. The internalized HhGFP at the A compartment is in green (white arrow 600 
heads). Note also that in the most basal section Hh puncta appear to be aligned in a ‘beads on a 601 
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string’ arrangement, suggesting they associate to cytonemes  (see also 6). D) Ex-vivo staining 602 
using an anti-GFP antibody in a UAS.HhGFP/UAS.IhogRFP; hh.Gal4/tubGal80ts wing disc after 24 603 
hours at the restrictive temperature. Note the colocalization between Hh and Ihog (arrow heads) 604 
in the A compartment and also the presence of externalized Hh at the cellular extensions marked 605 
by the Ihog protein. E) Dlp expression in a tubGal80ts; UAS.IhogYFP/hh.Gal4 wing disc for 24 606 
hours. e) Insets in E showing the colocalization of puncta of Ihog and Dlp (arrow heads) in the A 607 
compartment. F) Ectopic expression of UAS-IhogYFP and UAS-Disp using the hhGal4; tubGal80ts 608 
system for 24 hours. f) Insets in F show the colocalization of puncta of both proteins (arrow 609 
heads) in the A compartment.  G) Ex-vivo staining using an anti-Disp antibody in a UAS-610 
Disp/UAS-iHogCFP; hhGal4/tubGal80ts wing disc after 24 hours at the restrictive temperature. Note 611 
the colocalization of Disp, Dlp and Ihog in the A compartment (arrow heads)  (insets g). Bars,10 612 
µm. 613 
Figure 2: Hh and Ihog can complex with the exosome marker CD63 in vivo. A) Lateral view 614 
of a reconstructed z –stack of confocal images from a wing disc expressing the exosome marker 615 
UAS.CD63GFP and UAS.IhogRFP under the control of hh.Gal4/tubG80ts after 24 hours at the 616 
restrictive temperature and immuno-labeled for Hh. Note the colocalization of IhogRFP (red) and 617 
Hh (grey) with the marker CD63GFP21 (arrow heads). Bar 20 µm. B) Live imaging of Drosophila 618 
abdomen shows CD63GFP labelled puncta that co-localizes with puncta also labelled by IhogRFP 619 
(arrow heads) and that move along the cytoneme (See also Supplementary Movie 3). Bar 10 µm. 620 
C-E) Western Blots showing co-immunoprecipation of CD63GFP, IhogRFP and endogenous Hh 621 
after a GFP-Trap pull down (Chromoteck) from a High Speed Supernatant (HSS) of homogenized 622 
larvae expressing CD63GFP as control and larvae co-expressing CD63GFP and IhogRFP as 623 
expermiental. (C) Immunoprecipitation of CD63GFP shown for both, the IP control and the 624 
experimental IP (arrowhead). (D’) Co-immunoprecipitation of IhogRFP revealed by anti-RFP in the 625 
experimental IP (arrow) and not present in the IP control. D’’) Co-immunoprecipitation of 626 
 
 
26 
endogenous Hh revealed (after membrane antibody stripping) by anti-Hh in the experimental IP 627 
(asterisk) and not present in the IP control, probably due to an enrichment effect of the co-628 
expression of IhogRFP and CD63GFP.  629 
Figure 3. Punctate structures move along cytonemes in vivo. (A,B) CD63GFP labels punctate 630 
structures that move along cytonemes. Cells of the P compartment are labelled with 631 
hh.Gal4>UAS.CD63GFP. (A) Individual frames taken from Supplementary Movie 4. Black arrows 632 
indicate puncta. Fluorescence is depicted using an inverted grey lookup table61. (B) Individual 633 
frames taken from Supplementary Movie 5. Arrowheads indicate puncta. Fluorescence is 634 
depicted using a grey LUT (left) and a HiLo LUT (right), which highlights the brightest pixels in 635 
red. (C) Cytonemes labelled with CD4-Tomato show ‘buckling’ and ‘swelling’ (C). These 636 
structures might be related to the shedding of vesicles, which we could observe occasionally (see 637 
D). Individual frames taken from Supplementary Movie 6. Cells of the P compartment are labelled 638 
with hh.Gal4 >UAS.CD4-Tomato. Fluorescence is depicted using an inverted grey lookup table.. 639 
(D) Occasionally, we observe punctate structures shedding from the cytonemes. Individual 640 
frames taken from Supplementary Movie 7. Cytonemes reaching into the A compartment are 641 
labelled with hh.Gal4>UAS.IhogRFP and coloured with a fire look-up table. Left panel: Overview. 642 
Right panels: Time sequence of detail indicated in the overview. Note punctate structures, which 643 
are located along the cytonemes. One punctum (white arrows) is budding (cyan arrowheads) and 644 
finally shedding from the cytoneme (orange arrowhead).  645 
Figure 4: Ultrastructural localization of Hh in imaginal discs. Correlative light-electron 646 
microscopy of wing discs expressing Hh-GFP. Discs were labelled ex vivo with a rabbit anti-GFP 647 
antibody and then fixed and processed for cryosectioning. Ultrathin sections, cut orthogonally to 648 
the V/D axis, were incubated with a fluorescent (Alexa594) 1.4-nm nanogold-conjugated anti-649 
rabbit Fab´ probe. Labelled cryosections were first imaged at the fluorescence microscope (A1) 650 
and then at the transmission electron microscope after silver enhancement of the nanogold signal 651 
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(A2-F1). At the light microscopy level (A1) fluorescent labelling is detected at apical areas and at 652 
basolateral regions of the P compartment. At the EM level, apical immunogold labelling (B and B1 653 
shows the area delimited by a red box/square/rectangle in A) decorated microvilli membranes 654 
(arrows in B1) whereas basolateral signal (panels C1-C3 shows EM images of the area delimited 655 
by a blue square in A while D-F shows details of a different disc) is mainly associated with 656 
discrete extents of the plasma membrane (arrows in C1, C3 and D) that frequently coincide with 657 
cell-to-cell contacts (arrows in D). Also, immunogold labelling is detected in clusters of 658 
extracellular vesicle-like structures (arrowheads in panels C1.1, C3, D1, E1, E2 and F1), some of 659 
which are associated with cell protrusions (insets in C1 (C1.1) and E (E1)). A and P 660 
compartments as well as apical (Ap) and basolateral (Bs) regions are indicated in panels A1 and 661 
A2. To help the interpretation, apical and basolateral extracellular spaces are depicted in red (B) 662 
and blue (C1, C3, D, E and F), respectively. Panels A to C3 correspond to the same wing disc 663 
whereas panels D to F1 correspond to a different specimen. Abbreviations: LD (lipid droplet). 664 
Bars: 25 µm (A1 and A2), 5 µm (C), 500 nm (B, C2, D, E and F), 200 nm (B1, C1, C3, D1, E1 665 
and E2) and 100 nm (C1.1 and F1).  666 
Figure 5: Hedgehog protein is associated to EVs with features of exosomes.  A) A 667 
representative Western blotting of supernatants (SN1500 and SN45) and EVs obtained from 5 ml 668 
of media from mock- (control) or Hh-GFP- transfected Cl8 cells. Similar volume of supernatants 669 
(1/350 of the total) and 1/5th of the EVs were applied to the gel. Antibodies against indicated 670 
proteins were used as described in Materials and Methods. Antibody against Hh showed that Hh 671 
is found in EVs, although the Hh-associated to EVs represents less than 10% of the total 672 
secreted forms (n=3) B) EVs from Hh-GFP transfected cells were fractionated by continuous 673 
sucrose density gradient and equal amounts (1/5th) of the resulting fractions analysed by 674 
Western blotting. Specific antibodies show the presence of Hh and protein markers of exosomes 675 
(Ubiquitinated proteins, Hsp70, TSG101 and Rab11) mapping at similar densities. ApoLII was 676 
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also tested in the gradient, showing a different pattern along the gradient. C) Western blot 677 
analysis of Hedgehog protein in EVs obtained from untransfected Cl8 cells and extract from 678 
larvae stage 3 (L3). D) Luciferase activity in Cl8 cells transfected with ptcΔ136-GL3 Firefly 679 
responsible reporter and incubated without (Control) or with EVs obtained from Cl8 cells. Shh 680 
recombinant protein was used as positive inducer. Mean ± SD of three replicates is shown. 681 
Significance level (t-student test) **P<0.01. 682 
Figure 6: Hh signalling and release in mutant conditions for exosome production genes.  683 
A) Hh signalling in wing discs expressing RNAi treatments in the P compartment (b-d, f-h) and 684 
control (a,e), visualized in the A compartment using the Ptc-promotor-Trap::GFP reporter (a-d) 685 
and immunolabelling for the long range target Ci (e-h). Detail shown at the bottom and anterior is 686 
to the left. Note in RNAi wing discs (b-d, f-h), gradients are shorter than in controls (a,e). (d,h) 687 
Box plot comparing gradient length expressed as a proportion of wing pouch length, between 688 
control discs and treatments for each reporter. B) Quantification of the number of HhGFP (a-c) or 689 
IhogRFP (d) released punctate structures. Reconstruction in Z (lateral view) of wing discs 690 
expressing HhGFP 21 (a) or coexpressing HhGFP and RNAi for AnxB11 (b) under the control of 691 
hh.Gal4 and immunostained for the transcription target Ptc (red), note punctate structures in the 692 
A compartment, decrease after RNai treatment. (c) Boxplot comparing the number of HhGFP 693 
puncta released for the control (UAS.HhGFP) and ten exosome related treatments. Note the 694 
reduction in the number of puncta. (d) Boxplot comparing the number of IhogRFP puncta (anterior 695 
compartment) for the control (UAS.IhogRFP) and seven treatments related to exosome production. 696 
Note the reduction in the number of puncta. C) Endogenous externalized Hh levels decrease in 697 
mutant conditions for exosome production genes. Ex-vivo staining for Hh in wild type discs (a) or 698 
in wing disc expressing RNAi for TSG010 (b) driven by ap.Gal4 with a dorsal expression domain 699 
(marked by GFP), leaving the ventral domain in Wild Type conditions as an internal control. Note 700 
the decrease in fluorescence after treatment (a,b). (c) Boxplot showing the ratio between relative 701 
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intensity of the mean grey value in the dorsal (RNAi treated) versus the ventral compartment 702 
(Wild type). The ratio is close to 1 in control while ratio for all RNAi cases is greater than 1 due to 703 
a decrease in the levels of external Hh in treated cells. Significance levels for pairwise tests 704 
(Tukey HSD or Wilcoxon, depending on Normality of data): *** P<0.001, ** P<0.01, *P<0.05, + 705 
P<0.1.  Bars,10 µm. 706 
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SUPPLEMENTARY MATERIAL 
Supplementary Fig. 1: Ultrastructural localization of Hh, Ihog and Disp in wing discs. A) 
Thawed 200 nm thick cryosections of wing disc expressing HhGFP were immunostained with an 
anti-GFP antibody followed by a fluorescent (Alexa594) conjugated antibody and nuclear DAPI 
staining. HhGFP signal is localized along the apical lumen as well as in the basolateral region of 
the P compartment.  B, C, D, E, F, f) Correlative immunogold labelling of 100 nm thick 
cryosections with an anti-Hh antibody followed by protein A gold (15nm). Labelling decorated the 
apical microvilli along the entire disc lumen (arrows in B) as well as basolateral membranes 
(arrows in C and D), multivesicular bodies (MVB in C and E) and lysosomes in the Hh producing 
cells (C). Hh staining appears also associated with exovesicle-like structures (F, f) in basolateral 
spaces (depicted with blue colour in F).  G, H) Immunogold labelling of cryosections of wing discs 
expressing IhogCFP. Staining was performed with an anti-GFP antibody followed by protein A gold 
(15 nm). Labelling decorated MVBs (G) and exovesicles (arrowheads in G and H-h) at 
basolateral spaces. Note that in panel H, the basolateral space between adjacent cells (N 
indicates their nuclei) has been depicted in blue colour to better visualize gold-decorated 
exovesicles. I) Double-immunogold labelling of Hh and Disp on cryosections of wing disc 
expressing DispYFP. Labelling was performed with rabbit anti-Hh and guinea pig anti-Disp 
antibodies followed by 15nm gold conjugated anti-rabbit and 10-nm gold conjugated anti-guinea 
pig antibodies. Image shows double-labelled on basolateral membranes, MVBs and exovesicles 
(arrowheads) at basolateral spaces. Bars, 500 nm (F, H) and 200 nm (B,C,D,f,G,I). A and P 
compartments are indicated in A. Basolateral extracellular spaces are depicted in blue. 
Supplementary Fig. 2: Hedgehog and Ihog are in EVs dependent of the ESCRT complex.  
A) Western-blotting of three independent experiments of transfection in Cl8 cells with a vector 
carrying Hh-GFP.  1/30th of 1% Triton X-100-lysed cells, 1/5th of the purified EVs and 1/350th of 
the SN1500 and SN45 were analysed by Western-blotting using antibody against Hedgehog. 
Both, low and high exposures of the films are indicated in order to visualize the protein in all the 
fractions. B) Western blotting of cell extracts and purified EVs obtained from untransfected and 
S2 stably-expressing Hh-GFP cells. Equal amounts of proteins (20 ug) of 1% Triton X-100-lysed 
cells and of purified EVs were analysed using antibodies against indicated proteins. Note that 
while a tiny band was observed in cell extract of Hh-GFP expressing cells a clear band was 
observed in the EVs from Hh-GFP expressing cells indicating an enrichment of Hh-GFP protein in 
the extracellular vesicular fraction regarding the intracellular Hh content. C) Gradient density 
analysis of EVs from Hh-GFP stably-expressing S2 cells. EVs were fractionated by continuous 
sucrose density gradient and equal amounts (1/5th) of the resulting fractions analysed by 
Western blotting. Specific antibodies show the presence of Hh, iHog and exosomal marker 
Rab11 mapping at similar densities. D) dsRNA treatment against nSMase, TSG101 or Rab27 in 
Drosophila cultured cells Cl8. 
Supplementary Fig. 3: Methods for the quantification of puncta in the A compartment. A-a) 
Maximum intensity projection of Z stacks from a wing disc expressing IhogRFP (control), showing 
the rectangular area used for quantifications of the number of puncta in the A compartment, a) 
Image showing the selection used for quantification after delimiting the edge of the P 
compartment cells. a) Small numbers are the actual quantification showed here in a projection of 
the Z stacks. B-b) Example of another quantification for one of the RNAi treatments co-
expressing IhogRFP, showing the same image analysis procedure as in the control (A). All 
quantifications were performed per z-slice rather than using projections. C) Confocal sections of 
wing discs expressing HHGFP in the P compartment (hh.Gal4) and immuno-labelled for the 
receptor Ptc in the A compartment. Yellow line shows the delimitation of the edge obtained after 
blurring the projected image of all sections. Note how the delimiting line coincides with the 
compartment border marked by Ptc in red (c). 
Supplementary Fig. 4: Results are robust to controls for RNAi treatments A) Imaginal discs 
immunostained with anti-Caspase-3 antibody to analyse the effect of a possible cell death after 
RNAi treatments (b-d) when compared to a non-treated HhGFP expressing disc (a). Note that 
there is no significant increment in cell death. Bars,10 µm. B) Boxplot showing RNA levels after 
RTcPCR quantification in larvae expressing RNAi treatments and tested for their target genes. 
Note that there is a significant reduction in specific RNA levels when treated (See Methods). C) 
Immunostaining for total Hh in wild type discs (a) or in wing disc expressing RNAi treatment for 
AnxB11 (b) driven by ap.Gal4 with a dorsal expression domain (marked by GFP), leaving the 
ventral domain in Wild Type conditions as an internal control. Note there is no change in 
fluorescence levels at the dorsal posterior compartment compared to the ventral side (a,b). (c) 
Boxplot showing the ratio between relative intensity of the mean gray value in the dorsal (RNAi 
treated) versus the ventral compartment (Wild type). The ratio is close to 1 in control, and in all 
RNAi cases except TSG101 and Vps22 where the ratio decreases due to accumulation of Hh in 
the RNAi treated cells. 
Significance levels for pairwise tests (Tukey HSD or Wilcoxon, depending on Normality of data): 
*** P<0.001, ** P<0.01, *P<0.05, + P<0.1.  Bars,10 µm. 
Supplementary Fig. 5: Original films for all Western Blot experiments. A-C) Western Blots 
for co-immunprecipitation experiment (Fig. 2 C-E) incubated with antibodies against GFP (A), 
RFP( B) and Hh (C). D) Western Blots for the isolation of EVs showing Hh, ApoLII in EVs with 
exosomal markers (Fig. 5A). E) Western Blots for the fractionation of EVs by density gradient 
showing Hh, ApoLII and exosomal markers (Fig. 5B). F) Western Blots for the isolation of EVs 
showing HhGFP (Supplementary Fig. 2A). G) Western Blots for the isolation of EVs showing HhGFP 
and Ihog in EVs with exosomal markers (Supplementary Fig. 2B). H) Western Blots for the 
fractionation of EVs by density gradient showing HhGFP and Ihog with the exosomal marker 
Rab11 (Supplementary Fig. 2C). I) Western Blots for silencing experiments showing EVs with Hh 
and Syntaxin after dsRNA treatment against nSMase, TSG101 or Rab27 in Drosophila cultured 
cells Cl8 (Supplementary Fig. 2D). Thus WB was also used to show endogenous Hh (Vehicle 
lane) in EVs with a control for Hh expression from Larvae extracts (Fig. 5C) 
Supplementary Movies 
To observe all the details in these complex Movies, please use the arrow keys to play the Movies 
in Quicktime (Apple, Inc.). In all Movies, anterior is to the left. 
Supplementary Movie 1: 3D Reconstruction of a z-stack from apical to basal of a 
hh.Gal4>UAS.IhogRFP; UAS.HhGFP wing disc. Movie shows a disc rotated from above apical side 
to a lateral side. Note the presence of vesicles all along the lateral side and along cytonemes at 
the basal part of the disc. Bar,10 µm. 
Supplementary Movie 2. IhogRFP labels cytonemes and punctate structures in the abdominal 
epidermis in vivo. Histoblasts of the P compartment are labelled with hh.Gal4>UAS.IhogRFP. 
Lateral region of the epithelium shown in the top panel and basal region in the bottom panel. Note 
that besides the basal cytonemes, which reach into the A compartment, punctate structures can 
be found in the A compartment both basally and laterally. Bar, 10 µm. Anterior is to the left. 
Supplementary Movie 3. Punctate structures labelled with CD63GFP co-localize with those 
labelled with IhogRFP in vivo. Cells of the P compartment are labelled with hh.Gal4 >UAS.CD63-
GFP, UAS.IhogRFP. The white arrow highlights a protrusion, in which puncta are most noticeable. 
Bar, 5 µm.  
Supplementary Movie 4. Punctate structures labelled with CD63GFP move along cytonemes in 
vivo. Cells of the P compartment are labelled with hh.Gal4 >UAS.CD63GFP. The white arrow 
highlights a protrusion, in which puncta are most noticeable. Bar, 5 µm. 
Supplementary Movie 5. Punctate structures labelled with CD63GFP move along cytonemes in 
vivo. Cells of the P compartment are labelled with hh.Gal4 >UAS.CD63GFP. Arrowheads highlight 
puncta, which move along a protrusion. Fluorescence is depicted using a grey (left) and a HiLo 
lookup table (right), which highlights the brightest pixels in red. Bar, 10 µm. 
Supplementary Movie 6. Cytonemes labelled with CD4-Tomato show ‘buckling’ and ‘swelling’. 
The first arrows highlight ‘buckles’, the later ones ‘swellings’. Cells of the P compartment are 
labelled with hh.Gal4 >UAS.CD4-Tomato. Fluorescence is depicted using an inverted grey lookup 
table. Bar, 5 µm. 
Supplementary Movie 7. IhogRFP puncta move along cytonemes. P compartment cells and their 
cytonemes are labelled with hh.Gal4 >UAS.IhogRFP and coloured with a Fire lookup table. Note 
punctate structures, which are located along the cytonemes (white arrows). One punctum is 
budding and finally shedding from the cytoneme (cyan arrow indicates punctum shortly before it 
leaves the protrusion). Note also that IhogRFP labels puncta, which are not associated to 
cytonemes. Bar, 10 μm.  





Supplementary	Table	1:	Drosophila	stocks		
Name	
	(Symbol)	
TYPE	 Procedence	
Stock	Number	
FlyBase	ID		
(stock)	
	
FlyBase	ID		
(gene)	
	
Annotation	
symbol	
ALG-2	interacting	
protein	X		
(ALiX)	
UAS-RNAi	line	 Bloomington	Drosophila	Stock	Center	#33417	
FBst0033417	 FBgn0086346	 CG12876	
Annexin	B11	
(AnxB11)	
UAS-RNAi	line	 Vienna	
Drosophila	RNAi	Centre	#29693	 FBst0458097	 FBgn0030749	 CG9968	
Flotillin	2		
(Flo2)	
UAS-RNAi	line	 Vienna	
Drosophila	RNAi	Centre	#31525	 FBst0459071	 FBgn0264078	 CG32593	
Hepatocyte	
growth	factor	
regulated	tyrosine	
kinase	substrate	
(Hrs)	
UAS-RNAi	line	 Bloomington	Drosophila	Stock	Center	#33900	
FBst0033900	 FBgn0031450	 CG2903	
Rab11		
(Rab11)		
UAS-RNAi	line	 Vienna	
Drosophila	RNAi	Centre	#108382	 FBst0480193	 FBgn0015790	 CG5771	
aSMase		 UAS-RNAi	line	 Bloomington	Drosophila	Stock	Center	#25283	
FBst0025283	 FBgn0039769	 CG15534	
Tumor	
susceptibility	
gene	101	
(TSG101)		
UAS-RNAi	line	 Bloomington	Drosophila	Stock	Center	#35710	
FBst0035710	 FBgn0036666	 CG9712	
Vacuolar	protein	
sorting	4		
(Vps4)		
UAS-RNAi	line	 Vienna	
Drosophila	RNAi	Centre	#105977	 FBst0477803	 FBgn0027605	 CG6842	
Larsen	
(Vps22)		
UAS-RNAi	line	 Bloomington	Drosophila	Stock	Center	#38289	
FBst0038289	 FBgn0260940	 CG6637	
Vacuolar	protein	
sorting	24	
(Vps24)		
UAS-RNAi	line	 Bloomington	Drosophila	Stock	Center	#38281	
FBst0038281	 FBgn0037231	 CG9779	
YKT6	ortholog	(S.	
cerevisiae)	(Ykt6)		
UAS-RNAi	line	 Bloomington	Drosophila	Stock	Center	#38314	
FBst0038314	 FBgn0260858	 CG1515	
Cation–
transporting	P-
type	ATPase	
(TAT-5)	
UAS-RNAi	line	 Vienna	
Drosophila	RNAi	Centre	#105987	 FBst0477813	 FBgn0051729	 CG31729	
Hedgehog	 UAS-HhGFP	 Torroja	et	al.,	2004	 FBtp0019401	 	FBgn004644	 CG4637	
Ihog	 UAS-IhogRFP	UAS-IhogYFP	UAS-IhogCFP	 Bilioni	et	al.,	2013		Callejo	et	al.,	2011	
FBtp0083037	 FBgn0031872	 CG9211	
Apterus	 Gal4	 Bloomington	Drosophila	Stock	Center	#56807	 FBst0056807	 	FBgn0000099	 CG8376	
α-Tubulin	at	84B	 Gal4	 Bloomington	Drosophila	Stock	Center	
#30036	
FBst0030036	 FBgn0003884	 CG1913	
CD-63	 UAS-CD63GFP	 Panakova	et	al.,	2005	 FBtp0020578	 FBtp0020578	 ENSG00000135404		
Dispatched	 UAS-Disp		UAS-DispYFP	 Burke	et	al.,	1999	Callejo	et	al.,	2011	
FBtp0011804		FBtp0083034	 FBgn0029088	 CG2019	
Patched	 Promoter	enhancer	trap-GFP	(Spradling)	
DGRC		 Fly	Trap	GFP	CB02030	 FBgn0003892	 CG2411	
Hedgehog	 Gal4	 Takei	et	al.,	2004	 FBti0017278	 FBgn004644	 CG4637	
GFP	 UAS-EGFP	 Bloomington	Drosophila	Stock	Center	#5430	
	FBst0005430		 	FBtp0011396		 	
CD-4	 UAS-CD4-Tomato	 Han	et	al.,	2011	 FBtp0068019	 FBgn0263317	 ENSG00000010610						
